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1. Introduction 
Cancer is a disease in which uncontrolled cell division begins, cell integrity and 
transmission collapse. Cervical cancer is the second most common cancer among women 
worldwide. The oncogenic human papillomavirus (HPV) types are the most significant risk 
factors in its aetiology. HPV causes deformation of genomic integrity, control of cell cycle, 
cell adhesion and apoptosis by suppressing tumor suppressor genes and interacting with 
cellular proteins via various proteins on carcinogenesis process. While doing all these 
functions, HPV undoubtedly interacts with the members of cytoskeleton which enable 
cellular motility and integrity. This causes deformation of intercellular junction and tissue 
integrity. Formation of “koilos” which is created by HPV in cells and has an important place 
in the diagnosis of virus in gynecologic and non-gynecologic samples can be thought as the 
result of interaction of HPV-cytoskeleton. In this chapter the relation between HPV proteins 
and members of cytoskeleton will be studied through tumor suppressor genes. First of all 
HPV genomic structure and HPV proteins will be mentioned generally, then cytoskeleton 
and its members will be explained together with HPV proteins which they are in interaction 
with.  
2. HPV genomic structure and function  
Human papillomaviruses (HPVs) are small, nonenveloped, icosahedral, double-stranded 
circular DNA viruses belong to the Papovaviridae family. HPVs specifically infect keratinized 
stratified epithelia. The circular DNA approximetely 8,000 bp in size, contained within a 
spherical protein capsid, composed of 72 capsomers. The viral capsid has developed to 
complete several roles that are crucial to establish viral infection. The HPV genome is 
enclosed by an icosahedral capsid (T=7) of 55 nm in diameter composed by two structural 
proteins, the major protein L1 and the minor capsid protein L2 (Horvath et al., 2010; Howley 
1996; Longworth & Laimins, 2004; Prétet et al., 2007). To date, over 100 different viral types 
have been recognized and new types are regularly added to this list. These viruses can be 
classified into mucosal and cutaneous subtypes. Within each of these HPV groups, 
individual viruses are designated high risk or low risk according to their oncologic 
potential: high risk viruses such as HPV16,18 are frequently found in carcinomas. Low-risk 
types are responsible for benign lesions or condylomas (Blachon & Demeret, 2003, Howley 
1996; Longworth & Laimins, 2004; Mu¨nger et al,, 2004, Prétet et al., 2007). 
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HPV types belong to four of those genera, i.e., Alphapapillomavirus, Gammapapillomavirus, 
Mupapillomavirus and Nupapillomavirus have been associated with cutaneous warts, 
especially foot and hand warts (Koning et al., 2011). Genitally transmitted HPV types are 
contained within genus Alfapapillomavirus and viruses from this group, such as HPV 6 and 
11, are major sexually transmitted pathogens (Brentijens et al., 2002; de Villiers et al., 2004, 
Myers et al., 1994 as cited in Doorbar, 2005). These viruses are associated with benign 
papillomas. Contrary, the high-risk viruses from supergroup A, such as HPV16 and 18, 
cause mucosal lesions that can progress in some individuals to high-grade neoplasia and 
cancer (Bosch et al., 2002; Walboomers et al., 1999 as cited in Doorbar, 2005). The second 
major group of human papillomaviruses (also known as Beta papillomaviruses) are 
contained within supergroup B such as HPV5. This virus causes inapparent or latent 
infections in the general population (de Villiers et al., 2004; Myers et al., 1994; Ramoz et al., 
2002, as cited in Doorbar 2005). The third major group of human papillomaviruses (also 
known as Gammapapillomaviruses) are gamma papillomaviruses such as HPV4. This virus 
cause cutaneous warts in the general population that can superficially resemble those 
caused by supergroup A papillomaviruses such as HPV2. The remaining group of HPVs are 
contained within supergroup E (also classified as Mu and Nu-papillomaviruses (de Villiers 
et al., 2004, Myers et al., 1994 as cited in Doorbar, 2005). Only three human members from 
this group are known, and all cause cutaneous papillomas in the general population. HPV1 
is the most well studied member of this group, and like HPV2 in supergroup A, causes 
verrucas and palmar warts (Doorbar, 2005). 
The HPV genome includes several open reading frames (late and early gene regions and the 
non-coding long control region (LCR) that encode proteins involved in viral DNA 
replication (E1 and E2), viral gene expression regulation (E2), virus assembly (E4) and the  
immortalisation and transformation of infected epithelial cells (E5, E6 and E7; high-risk HPV 
only). These proteins play a role in genome organization, regulation of gene expression, and 
cellular transport. HPV proteins and their functions were documented in Table 1. The open 
reading frames L1 and L2 encode the two capsid proteins (Howley 1996; Prétet et al., 2007). 
These proteins are expressed in the upper layers of infected tissue (Ozbun & Meyers, 1998, 
as cited in Doorbar, 2005). HPVs L1 and L2 capsid proteins form the structure of the virion 
and facilitate viral DNA packaging and maturation.   
The papillomavirus E1 and E2 proteins play significant roles in viral genome replication. 
(Munger et al., 2004). The E1 protein also exhibits DNA helicase/ATPase activity (Hughes & 
Romanos 1993, Longworth & Laimins, 2004). E1 proteins bind to specific DNA elements in 
the viral origin of replication and assemble into hexameric helicases with the assist of a 
second viral protein, E2 (Wilson et al., 2002). The viral E2 protein is also crucial for the viral 
origin of replication (Dao et al., 2006). E2 plays a role in regulating viral transcription from 
the early promoter and viral genome segregation during cell division (Haugen et al., 1987 as 
cited in Longworth & Laimins, 2004, Munger et al., 2004). 
E6 and E7 oncoproteins, encoded by the oncogenic HPV types, are responsible for malignant 
transformation. These proteins disrupt normal cell growth and proliferation by binding to 
tumor suppressors proteins such as p53 and retinoblastoma (pRb) (Burd, 2003, Gammoh et 
al., 2006). High risk HPV E6 protein interacts with many significant cellular protein. To 
examplify these cellular protein, EF-hand calcium-binding protein E6-BP (reticulocalbin 2), 
the interferon regulatory factor IRF-3, and the focal adhesion protein paxillin (Munger et al.,  
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Table 1. HPV proteins and their functions.  
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2004). E6 also binds the p53 as part of a trimeric complex with the cellular ubiquitin ligase, 
E6AP, leading to the rapid turnover of p53 (Scheffner et al., 1990; Werness et al., 1990 as 
cited in Longworth & Laimins, 2004). 
HPV E7 proteins are low-molecular-weight proteins of approximately 100 amino acids. This 
oncoprotein encoded by small DNA tumor viruses, they associate with and adjust the 
functions of cellular protein complexes. The HPV E7 proteins interact with the 
retinoblastoma (Rb) family of tumor suppressors protein and the related “pocket proteins” 
p107 and p130. The proteins control the activities of the E2F family of transcription factors 
that regulate multiple cell cycle transitions as well as other cellular activities (Munger et al., 
2004). E7 also binds to other proteins such as  p130, p21, p27, cyclin A, cyclin E, the cyclin 
dependent kinase inhibitor (CKI), TBP,P300/CBP, MPP2,IGFBP-3, Mi2, NuMA (nuclear 
mitotic apparatus protein 1), p600. and a cellular protein kinase activity (Dyson et al., 1989 
as cited in Longworth & Laimins, 2004; Jones and Munger, 1996; Pim and Banks, 2010).  
HPV-16 may not only inactivate the tumor suppressor proteins p53 and pRB with its E6 and 
E7 oncoproteins, respectively, but could also alter other cellular functions through E7 
interaction with the cytoskeleton or associated proteins (Rey et al.,2000). Causing both 
benign and malignant lesions, HPV must first infect the divisible basal cell to induce 
papilloma formation (Burd, 2003; Flores et al., 2000; Howley 1996; Stanley, 2001). Viral 
replication occurs concomitantly with epithelial cell differentiation. Entering the basal cell, 
HPV replicates simultaneously with epithelial cell differentiation and reaches the 
keratinized cell (Andersson et al., 2005; Burd, 2003; Flores et al., 2000; Hoory et al., 2008; 
Howley 1996; Stanley, 2001).  
The E4 protein is the most abundantly expressed HPV protein. HPV E1^E4 accumulates in 
differentiating cells of the upper epithelial layers. It is synthesized from a spliced mRNA, 
E1^E4, which encodes five amino acids from the E1 ORF spliced to the protein encoded by 
the E4 ORF (Chow et al.,1987, Doorbar et al., 1990, Nasseri et al., 1987 as cited in Raj et al., 
2004). The first activity described for the 10-kDa HPV type 16 (HPV16) E1^E4 protein was 
its ability to bind and collapse the cytokeratin network (Doorbar et al., 1991 as cited in  Raj et 
al., 2004). Although all of the role of HPV16 E1^E4 is unclear, previous work has revealed 
that HPV16 E1^E4 can interact with keratins and cause the reorganization of the keratin 
intermediate-filament network (Doorbar et al., 1991 as cited in Wang et al., 2004). The HPV 
16 E1^E4 protein binds to keratins directly and interacts strongly with keratin 18, a member 
of the type I intermediate-filament family. By contrast, HPV16 E1^E4 bound only weakly to 
keratin 8, a type II intermediate-filament protein, and showed no detectable affinity for the 
type III protein, vimentin (Wang et al., 2004). 
The product of the E5 oncogene in HPVs contributes to cellular transformation. HPV16 E5 is 
a highly hydrophobic protein. It found mainly at the Golgi apparatus and internal 
membranes (Conrad et al., 1993 as cited in Alonso and Reed, 2002). Little is known about the 
biological activities of the HPV16 E5 protein or the source of its oncogenicity. It has been 
shown that E5 is able to regulate epidermal growth factor receptor (EGFR) activation in the 
presence or absence of ligand, and that expression of the protein in human keratinocytes 
results in altered gap junction-mediated cell–cell communication (Alonso and Reed, 2002). 
HPV E5 is also known to interact with growth factor receptors and gap junction proteins 
and is believed to play a role during the initiation of neoplasia (Yang et al., 2003). 
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Most benign and low-grade cervical lesions contain HPV DNA in an extrachromosomal 
state (Durst et al., 1985 as cited in Martineza 2007). However, in most cases of cervical 
carcinomas the HPV DNA is usually found integrated into the host chromosomes, 
frequently disrupting the E1 and E2 genes (zur hausen, 2000, 2002; Durst et al., 1985; 
Meissner et al., 1989 as cited in Martinez 2007). This process result in increased expression of 
the viral E6 and E7 oncogenes (Yee et al., 1985 as cited in Martinez 2007).  
A common feature of Human papillomavirus infection is the appearance of koilocytosis in 
the differentiated layers of squamous epithelium. Koilocytosis is the most common 
cytopathic effect and is considered by pathologists to be the major histopathological aspect 
for determination of HPV infection. Koilocytosis is composed of the presence of abnormal 
koilocytes. The greatest change caused by HPV in the epithelial cell cytoplasm is called 
koilos. Koilos means “hollow” in Greek. These koilocytes are squamous epithelial cells that 
may contain an acentric hyperchromatic nucleus and large clear perinuclear halos that 
usually occupy a greater volume than that of the cytoplasm (Fornatora et al., 1996; 
Krawczyk et al., 2008; Miyahara et al., 2011, Safi Oz et al., 2009, Safi Oz, 2010). The multiple 
nuclei of koilocytes are in fact multilobation of a single nucleus, and this phenomenon is 
associated with upregulation of gene products related to the G2 chectpoint. On restoration 
of 3D confocal images, the multinucleated feature of koilocytes was revealed to be 
multilobation of a single nucleus, as opposed to true multinucleation (Cho, 2005, 2006). 
HPV causes various changes through its structural proteins in the cytoplasms and nuclei of 
the cells and tissues it infects (Krawczyk et al., 2008, Safi Oz et al., 2009, Safi Oz, 2010, 
Fornatora et al. 1996 as cited in Miyahara et al., 2011). The formation of koilos is influenced 
by the structural proteins of the virus, cell skeletal filaments, and tumour suppressor genes. 
Modifications of the cytoskeleton as a result of viral protein expression have been associated 
with oncogenic transformation by papillomaviruses. HPV proteins are interacted with cell 
skeletal filaments. Some of these proteins are E6 (HPV16,18), E7 (HPV16,18,38), E5 (high and 
low risk HPV types), E1^E4 (HPV16), E4 proteins (Lee & Dominguez, 2010; McIntosh et al., 
2010; Nguyen 2008; Rey et al., 2000, Safi Oz, 2010; Stanley, 2001; Uribe & Jay., 2009; Yue et 
al., 2011). 
3. HPV proteins in relation with cytoskeletal filaments and interaction 
mechanisms 
Malignant transformation occurs with the alteration of cytoskeleton (Ben-Ze’ev 1997 as cited 
in Akgul et al., 2009). All these chances occur in different stages of cell cycle. Disruption of 
cytoskeleton not only means disruption of cytoskeletal organization but also disruption of 
many cellular functions. In this section, first of all cytoskeleton, its members and functions 
will be mentioned briefly. Then HPV proteins which are known and thought to have 
relation with cytoskeleton due to studies carried out until today will be explained. HPV 
proteins and cellular molecules interacted with cytoskeletal filament disruption were 
documented in Table 2)  
The cytoskeleton is a network of fibers throughout the cell's cytoplasm that helps the cell 
maintain its shape and gives support to the cell. In addition to providing support for the 
cell, the cytoskeleton is also involved in cellular motility and in moving vesicles within a 
cell, as well as assisting in the formation of food vacuoles in the cell. A variety of cellular 
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organelles are held in place by the cytoskeleton. The cytoskeleton is made up of three 
different types of protein filaments: microtubules, actin filaments (microfilament) and 
intermediate filaments. Each type of filament has different mechanical possestions and 
dynamics, but certain fundamental principles are common to them all (Alberts et al.,2002; 
http://biology.about.com/od/cellanatomy/a/aa013108a.htm). 
Actin filaments determine the shape of the cell’s surface and are necessary for whole cell 
locomadation. The actin cytoskeleton is a critical part of the cellular activities such as cell 
shape, cell division, motility, contraction, focal adhesion, phagocytosis, protein sorting and 
signal transduction (Lee & Dominguez 2010; Uribe & Jay 2009). Actin filament’s usefullness 
to the cell depends on a large number of accessory proteins that link the filaments to other 
cell component. These proteins are essential for the control assembly of the cytoskeletal 
filaments in particular locations (Alberts et al., 2002). Cell movement is an important 
phenomenon in embryonic morphogenesis, immune surveillance, angiogenesis and tissue 
repair and regeneration (Hussey et al., 2006; Itoh and Yumura, 2007; McMahon and Gallop, 
2005; Puppo et al., 2008; Yamaguchi and Condeelis, 2007 as cited in Lee & Dominguez, 
2010). Two transition types (monomeric or G actin and filamentous or F actin) of actin 
filaments are in cells (Uribe & Jay 2009). Schematic representation of monomeric and 
filamentous actin were seen in Figure. 1. 
The actin filament is asymmetric; actin monomers join the barbed (or +) fast growing end of 
the filament in the ATP-bound state and depart the filament preferentially from the pointed 
(or -) end primarily in the ADP state, giving rise to a process known as actin filament 
threadmilling. The transition between two types of actin is tighty regulated in cells by a 
large number of Actin-Binding Proteins (ABPs)  (Lee & Dominguez, 2010; Uribe & Jay 2009). 
ABPs carry out a wide range of functions, including actin filament nucleation, elongation, 
severing, capping, and crosslinking and actin monomer sequestration (Lee & Dominguez 
2010). The reorganization of the actin cytoskeleton is regulated in time and space by 
multiple factor, most notably Rho family GTPases that act as GTP-dependent molecular 
switches (Raftopoulou and Hall, 2004 as cited in Lee & Dominguez 2010). Among the small 
GTPases of the Rho family, Cdc42, Rac, and Rho are recognized as the most important 
regulators of actin assembly, controlling respectively the formation of filopodia, 
lamellipodia, and stress fibers (Etienne- Manneville and Hall, 2002 as cited in Lee & 
Dominguez 2010). Signals transmitted through these GTPases lead to localized actin 
cytoskeleton assembly/disassembly at the plasma membrane, with the actin filaments 
acting to push the cellular membrane (Hall, 1994 as cited in Lee & Dominguez 2010).  
By interacting with paxillin, E6 protein facilites transformation by disrupting the normal 
links between paxillin and the actin cytoskeleton by displacing paxillin-LD motif-binding 
proteins, disrupts the actin filament formation and the regulation of cytoskeleton (Cooper et 
al., 2007; Safi Oz et al., 2009, Rapp & Chen, 1998, Turner, CE., 2000). In the light of this 
information, the disruption of actin filament formation and thus, cytoskeleton disruption are 
believed to affect the formation of koilos around the nucleus (Safi Oz et al., 2009, Rapp & 
Chen, 1998, Cooper et al., 2007). With HPV disrupting actin filament formation, it is thought 
that cell shape and division, motility, contraction, focal adhesion and phagocytosis may be 
influenced.  
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Fig. 1. Schematic representation of monomeric and filamentous actin  
The bovine papillomavirus (BPV) E6 oncoprotein also interacts with paxillin and disrupt the 
actin cytoskeleton. HPV16 E6 binding to paxillin may contribute to the carcinogenic 
potential of the human papillomavirus (HPV). The association of HPV16 E6 with paxillin 
was affected by depolymerization of the actin fiber network. Disruption of the actin 
cytoskeleton is a characteristic of many transformed cells. (Tong & Howley, 1997). 
HPVE6 interacted with numerous proteins involved in adhesion, cell architecture and 
polarity. hDLG (the mammalian homologue of the Dropsophila discs large tomour 
suppressor protein), hScrib and MUPP control cell polarity and cellular scaffolds, and their 
interaction with E6 would lead to deregulation of cytoskeletal organization and cell–cell 
interactions (Campo, 2005). E6 also interact with the calcium binding protein ERC 55 and the 
paxillin, interactions that could lead to the disruption of the actin cytoskeleton and cell 
matrix interactions. Paxillin is a protein associated with focal adhesion kinase (FAK), a 
kinase that plays a regulatory role in cell migration, and vinculin and involved in the 
regulation of the cytoskeleton. Paxillin takes role in the regulation of actin cytoskeleton by 
interacting with other adhesion proteins in the cell such as actopaxin and vinculin. When 
Human Papillomavirus E6 protein is associated with paxillin, interaction of paxillin with 
other adhesion proteins therefore formation of actin cytoskeleton is disrupted. (Table 2) 
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HPV proteins Cellular molecules 
Types of 
cytoskeletal 
filamets
Effects 
HPV 16 E5 
Golgi apparatus
Endoplasmic reticulum 
Cellular membrane 
 
 
 
 
 
 
 
 
 
Actin filament 
 
 
 
 
Inhibits 
endocytotic 
activity 
HPV 16 E6 
Paxillin
(disrupt paxillin and vinculin, 
actopaxin interaction) 
Disruption of 
actin filament 
ERC55 (calcium binding 
protein)
hDLG (the mammalian 
homologue of the 
Dropsophila discs large 
tomour suppressor protein) 
hScrib  
MUPP
Tight junction complex
HPV 16 E7 
Unknown 
Disruption of 
actin filament HPV 38 E7 
HPV 16 E7 
Microtubule network
(attaches to microtubule 
network via the motor 
protein complex dynein) 
NuMA ( Nuclear Mitotic 
Apparatus Protein 1) /dynein 
network
Microtubule 
Disruption of 
microtubule 
motors and HPV 
associated 
tumorigenesis. 
Mitotic errors 
HPV 16 L2 
Microtubule network
(attaches to microtubule 
network via the motor 
protein complex dynein)
Disruption of 
microtubule 
motors 
HPV E4 Cytokeratin
Intermediate 
filament 
Total collapse of 
the cytokeratin 
matrix HPV E1^E4 
Cytokeratin 
DEAD-BAX protein 
Table 2. HPV proteins and cellular molecules interacted with cytoskeletal filament disruption 
HPVE6, specifically targets p53 for inactivation in order to promote cell growth and 
transformation and tumor supressors such as MAGI-1 and SAP97/hDlg for degradation. 
HPVE6 also targets numerous cellular proteins involved in a variety of cellular processes 
such as calcium signaling, cell adhesion, transcriptional control, DNA synthesis, apoptosis, 
cell cycle control, DNA repair, and small G-protein signaling. (Das et al., 2000, Degenhardt 
& Silverstein, 2001, Filippova et al, 2002, Gao et al., 1999, Gao et al., 2000, Iftner et al., 2002, 
Kuhne & Banks, 1998 Tong and Howley, 1997 as cited in Zhang  et al., 2007). Cellular targets 
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for the E6 proteins from high-low risk HPV types are Bak, myc, E6AP, E6BP⁄ERC55, P300 
⁄CBP, PDZ proteins, hTERT, Tyk2, hAda3 (Pim and Banks, 2010). HPV E6 interacts with 
tight junction complex (Zhang et al., 2007). Tight junction acts as an impermeable barrier 
that divides epithelial cells into functionally distinct apical and basolateral membrane 
domains (Yeaman et al., 1999 as cited in Zhang., 2007). Tight junctions consist of several 
transmembrane proteins (occludin, claudins, and junctional adhesion molecule). All these 
proteins are associated with at least one of the Zonula occludens proteins (ZOPs). ZOPs 
bind to the junctional transmembrane proteins linking them to the actin cytoskeleton. So, 
ZOPs establish a link between the junction site and the cytoskeleton by interacting directly 
with actin filaments (Fanning et al., 1998, Itoh et al., 1997, Wittchen et al., 1999 as cited in 
Traweger et al., 2003). ZOPs currently comprising ZO-1, ZO-2, and ZO-3, belong to the 
family of membrane-associated guanylate kinase homologue (MAGUK) proteins. MAGUK 
proteins are involved in the organization of epithelial and endothelial intercellular junctions 
(Traweger et al., 2003 as cited in Bauer et al., 2010). HPV E6 polypeptide binds to MAGUK 
Proteins (Zhang et al., 2007). The ZO-2 protein is targeted by HPVE6. ZO-2, a 160-kDa 
phosphoprotein and was found to co-precipitate with ZO-1 in epithelial cells (Gumbiner et 
al., 1991, Jesaitis and Goodenough, 1994 as cited in Traweger et al., 2003). 
ZOPs not only associate with each other but also with components of adherens junctions 
and gap junctions in cells lacking (Gumbiner et al., 1991, Howarth and Stevenson, 1995 as 
cited in Traweger et al., 2003). Adherens junction is responsible for cell-cell adhesion 
(Gumbiner, 1996 as cited in Zhang., 2007). The disruption of adherens junction decreases the 
phosphorylation of E-cadherin by protein kinase CK2, and this process of downregulation is 
treated as a common event in carcinogenesis (Serres et al., 2000 as cited in Zhang., 2007). 
Tight junction disruption and apobasical activity directly contribute to carcinogenesis by 
deregulating normal proliferation and differentiation programs in epithelial cells (Matter & 
Balda et al., 2003 as cited in Zhang., 2007). It is also thought that the damage caused by HPV 
on E6 proteins and tight junctions on carcinogenesis process is important.  
HPV-16 may not only inactivate the tumor suppressor proteins p53 and pRB with its E6 and 
E7 oncoproteins, respectively, but could also alter other cellular functions through E7 
interaction with the cytoskeleton or associated proteins. The E7 oncoprotein of Human 
Papillomavirus type 16 interacts with F-Actin in vitro and in vivo. F-actin is part of cellular 
structures such as microfilaments and the cell cortex and interacts with several structural 
and regulatory components. F-actin modifications resulting from viral protein expression 
will not only affect cytoskeletal organization but can also disrupt several cellular functions 
(Rey et al, 2000).  
Yue et al. showed that HPV38 E7 induces actin stress fiber disruption, and this phenomenon 
correlates with its ability to down-regulate Rho activity. In addition, HPV38 E7 is able to 
induce actin fiber disruption by directly binding to the eukaryotic elongation factor 1A 
(eEF1A) and abolishing its effects on actin fiber formation. Their data support the conclusion 
that HPV38 E7 promotes keratinocyte proliferation in part by negatively regulating actin 
cytoskeleton fiber formation and by binding to eEF1A and inhibiting its effects on actin 
cytoskeleton remodeling (Yue et al., 2011). 
The second type of cytoskeletal filament is the microtubule. Microtubules determine the 
positions of membrane-enclosed organelles and direct intracellular transport. Microtubules 
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are formed from protein subunits of tubulin (alpha-tubulin and beta-tubulin)  (Alberts et al., 
2002). Construction of microtubules was seen in Figure 2.  
 
Fig. 2. Construction of microtubules from ┙ and ┚ tubulins 
Romani et al. showed that the effect of HPV transformation on cellular cytoarchitecture. 
Cells from laryngeal papillomas and normal epithelium were cultured in vitro. Cytoskeletal 
components of both types of cells were visualized by immunofluorescence, to determine 
whether there were any differences in the structure or distribution of the cytoskeleton. The 
intermediate filaments and actin filaments are altered in the papilloma cells but there isn’t 
significant change in microtubules (Romani et al., 1987). (Table 2) Most of the studies carried 
out up-to-now are about HPV proteins and motor proteins. HPV16 E7 expresion leads to an 
increased population of mitotic cells with dynein, a minus end–directed microtubule motor 
protein, delocalized from the mitotic spindle. Dynein is composed of several subunits. The 
dynein motor complex aids in the positioning of the Golgi complex and mitochondria, along 
with other organelles, and transports cargo from the endoplasmic reticulum, endosomes, 
and lysosomes. It is possible that the disruption of microtubule motors by high-risk HPV 
may contribute to HPV associated tumorigenesis (Nguyen et al., 2008). The other type of 
motor protein is kinesin. Kinesin uses the energy of ATP hydrolysis to move along a 
microtubule. These proteins have legs and feet that change conformations by binding and 
hydrolyzing ATP to walk along the microtubules.  
Also HPV16 L2 protein attaches to microtubule network via the motor protein complex 
dynein (Florin et al., 2006; Schneider et al., 2011). The viral capsid play a critical role in the 
establishment of the viral infection. The L2 protein is an internally located multifunctinal 
protein with roles in genome encapsidation (Schelhaas et al., 2008, Holmgren et al., 2005 as 
cited in Horvath et al., 2010). Papillomaviruses enter cells via endocytosis. After endocytic 
cell entry and egress from endosomes, HPV16L2 goes along with the viral DNA to the 
nucleus. HPV16 L2 protein may be involved in the intracytoplasmic transport of the viral 
genome (Florin et al., 2006; Schneider et al., 2011).  
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The high-risk HPV16 E7 expression leads to the delocalization of dynein from mitotic 
spindles via an association with Nuclear Mitotic Apparatus Protein 1 (NuMA). The 
disruption of the NuMA/dynein network may result in mitotic errors (Nguyen, 2008, 2009). 
It is hypothesized that these event may important role in chromosome alignment and viral 
persistance (Nguyen &  Munger.,  2009). 
The third type of cytoskeletal filament is the intermediate filament. Intermediate filaments 
(IFs) provide mechanical strenght and resistance to share stres (Alberts et al., 2002). 
Intermediate filament-associated diseases clearly represent a significant group of human 
pathologies, and these pathologies that have given us the best clues to the function of this 
type of cytoskeleton component (Penky & Lane, 2007). Intermediate filaments are composed 
of smaller subunits that are themselves elongated and fibrous, but actin filaments and 
microtubules are made of compact and globular subunits (Alberts et al., 2002).  
IFs is a highly elongated, rod-like dimer based on an ┙-helical coiled-coil structure. 
Assembly of cytoplasmic IF proteins, such as vimentin, begins with a lateral association of 
dimers into tetramers and gradually into the so-called unit-length filaments (ULFs)  
(Strelkov et al., 2003). The molecular organisation of the intermediate filaments is specific for 
the cell type, the developmental stage and the type of differentiation (McIntosh et al., 2010). 
Major types of intermediate filament proteins in vertebrate cell are nuclear, vimentin-like, 
epithelial and axonal IF. Nuclear IF are composed of lamin A, B and C. The nuclear lamins 
are filamentous proteins, providing the nucleus with a putative skeleton for chromatin 
attachment (Alberts et al., 2002, Carmo-Fonseca &David-Ferreira , 1990). 
Different families of intermediate filaments are keratins, neurofilaments, vimentin-like 
filaments. Neurofilaments are found in concentrations along the axons of vertebrate 
neurons. Neurofilament proteins are NF-L, NF-M, NF-H. The vimentin-like filaments are 
found in muscle, glial cells, many cells of mesenchymal origin and some neurons (Alberts et 
al., 2002). The most diverse intermediate filament family is that of the keratins. Keratins are 
major structural proteins in epithelial cells and form the cytoplasmic network of 
intermediate filaments (Fuchs et al., 1998 as cited in Wang et al., 2004). Every keratin 
filament is made up of type I (acidic) and type II (neutral/basic) keratin chains (Alberts et 
al., 2002). The keratin IF network of epidermal keratinocytes provides a protective barrier 
against mechanical insult, it is also a major player in absorbing stress in these cells  
(McIntosh et al., 2010). They contain at least 20 members, called keratin 1 (K1) to K20, which 
are divided into two types according to the sequence and isoelectric point (pI). K9 to K20 are 
type I (acidic) keratins. The type II keratins, K1 to K8, are neutral or basic. Type I and type II 
keratins form noncovalent heteropolymers at a 1:1 ratio (Moll et al., 1998 as cited in Wang et 
al., 2004). Recently, several new functions of keratins have emerged. K8 and K18 prevent 
Fas- and possibly tumor necrosis factor-induced apoptosis (Caulin et al., 1998, Gilbert et al., 
2001, Inada et al., 2001, Ku et al., 2003 as cited in Wang et al., 2004). Keratin intermediate 
filaments are highly dynamic structures and are reorganized during cellular events such as 
mitosis and apoptosis (Wang et al., 2004). Diversity of keratins is clinically useful in the 
diagnosis of epithelial carcinomas, as the particular set of keratins expressed gives an 
indication of the epithelial tissue in which the cancer originated and thus can help to guide 
to choise of treatment (Alberts et al., 2002). HPVE4 interacts with the keratin cytoskeleton 
and intermediate filaments (Campo, 2005). Recent studies have introduced a new protein 
named E1^E4 of HPV16 that could disrupt the epithelial cytoskeleton. This protein is 
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encoded by spliced mRNAs that fuse the two early genes, E1 and E4, which encodes five 
amino acids from the E1 ORF spliced to the protein encoded by the E4 ORF , and is the most 
abundantly expressed viral protein in HPV-infected epithelia (Doorbar et al., 1991 as cited in 
Ohta & Nishiyama, 2011). It has been reported that this protein degrades the cytoskeleton by 
interacting with epithelial cell proteins (Davy et al., 2002, Nakahara et al.,2002 ). (Table 2) 
Doorbar et al showed that expression of the HPV-16 E1^E4 protein in human keratinocytes 
(the natural host cell for HPV infection) results in the total collapse of the cytokeratin matrix. 
Tubulin and actin networks are unaffected by E1-E4, as are the nuclear lamins  (Doorbar et 
al., 1991). The human HPV16 E1^E4 protein is associate with and reorganise the keratin IF 
network in cells in culture. HPV16 E1^E4 was found to effect a dramatic cessation of keratin 
IF network dynamics by associating with both soluble and insoluble keratin. These 
observations shed new light on the mechanism of keratin IF network reorganisation 
mediated by HPV16 E1^E4 (McIntosh et al., 2010). E1^E4 also translocates to mitokondria 
via an N-terminal leucine-rich region and induces the detachment of mitocondria from 
microtubules. The detached mitochondria then aggregate adjacent to the nucleus (Ohta & 
Nishiyama, 2011). 
HPV16 E1^E4 protein is the most abundantly expressed viral protein in HPV infected 
epithelia. HPV E1^E4 possesses the ability to bind to the cytokeratin network by interacting 
directly with cytokeratins and to DEAD-box proteins. Keratin association leads to the 
eventual  reorganization of the cytokeratin network in vivo as well as in vitro (Wang et al., 
2004 as cited in Raj  et al., 2004). Interestingly, the collapse of the network appears to initiate 
from the plasma membrane. Once collapsed, the cytokeratin appears as a cluster beside the 
nucleus. 
HPV16 E1^E4 is also able to prevent the progression of cells into mitosis by arresting them 
in the G2 phase of the cell cycle.  
HPV16 E1^E4 protein binds to mitochondria after binding to and collapsing the cytokeratin 
network and induces the detachment of mitochondria from microtubules, causing the 
organelles to form a single large cluster adjacent to the nucleus. This is followed by a severe 
reduction in the mitochondrial membrane potential and an induction of apoptosis (Raj et al., 
2004). 
In addition to the proteins mentioned above, it is expressed that HPV E5 protein contributes 
to the formation of koilocytes together with E6. The HPV E5 proteins are small (83 amino 
acids) hydrophobic proteins whose biological functions remain unresolved. These proteins 
are localized to endosomal membranes and the Golgi but on occasion are found in the 
cellular membranes (Longworth & Laimins, 2004). This protein associates with Golgi 
apparatus, endoplasmic reticulum and cellular membrane and inhibits endocytic activity by 
linking actin cytoskeleton. Although the role of HPV E5 in the cell-cycle is not known 
completely, it was shown with studies carried out on rodents that it shows low oncogenic 
activity in addition to major oncoproteins E6 and E7 (Kabsch & Alonso, 2002; Suprynowicz 
et al., 2008; Yang et al., 2003 as cited in Safi Oz., 2010). E6 protein in low and high risk HPV 
types aims at p53 and PDZ protein which organizes membrane transport in polarized 
epithelial cell membrane and may be damaging cell cytoskeleton (Safi Oz 2009, Krawczyk et 
al., 2008). HPV E5 – cell cytoskeleton association is an issue which requires more detailed 
biochemical and cellular studies.  
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4. Conclusion 
Here, I summarize recent progress in my understanding of the interaction between Human 
papillomavirus proteins and their ability to disrupt cytoskeletal filaments. Disruption of cell 
cytoskeleton causes the occurrence of some important diseases such as cancer. Disruption of 
cell cytoskeleton both causes the disruption of cellular motility and cellular integrity and 
failure of important biological events such as cell division, contraction and phagocytosis. 
Association of various viruses with cell cytoskeleton is a study issue which has been gaining 
importance in recent years. HPV is included in this group of virus. In the studies of cell 
cytoskeleton – HPV, HPV16 and 18 which are among the risky group in the sense of cancer 
formation, become prominent. E6 protein of HPV16 and 18, E5 protein of HPV 16 and E7 
protein of HPV38 associate with the members of actin cell cytoskeleton and damages cell 
cytoskeleton. Moreover, HPV E6 associates through MAGUK (membrane-associated 
guanylate kinase homologue) proteins with tight junctions which form impermeable barrier 
between apical and basal membrane domains. Although studies show that actin and 
intermediate filaments in papilloma cells alter but there are no significant alterations in 
microtubules; more detailed studies are required on this subject. In association of HPV – 
microtubule, some studies have been shown in which HPV16 minor capsid protein L2 and 
E7 link with microtubule network via motor protein dynein. Moreover it was stated that 
HPV16 E7 causes dynein delocalization via Nuclear mitotic apparatus (NuMa). I am of the 
opinion that there are few studies upon HPV and kinesine from motor proteins; 
enlightenment of this subject will direct the association of HPV–microtubule. 
Comprehensive understanding of HPV-cytoskeleton interaction will offer new insights into 
the HPV life cycle as well as karcinogenesis. This virus- cytoskeleton interaction will also 
provide a paradigm for investigating other DNA tumor viruses that share a similar 
mechanism for interacting with cytokeratin filaments.  
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